Skip to main content

J&J's Suffers a $417 M Loss In The First Ca. Talcum Trial

J&J's Suffers a $417 M Loss In The First Ca. Talcum Trial

J&J's Suffers a $417 M Loss In The First Ca. Talcum Trial

Introduction

One of the largest verdicts was announced in favor of the plaintiff this August by a California jury: J&J was ordered to pay $417 which included $347 million in punitive damages and $70 million in compensatory damages, making it one of the highest verdicts amounts for a Talcum powder trial.

In January 2017, a California state judge had scheduled an early July trial for a woman who alleged that she had less than six months to live due to ovarian cancer caused by Johnson & Johnson's talcum powder. The case proceeded as per the order with evidence produced by the plaintiff's end by an epidemiologist who opined that after reviewing the general link between the use of talcum powder and ovarian cancer; he felt that the talcum could cause ovarian cancer. However, he stated that he had not reviewed the details of the case.

This was also the first trial set in the coordinated proceedings in Johnson & Johnson Talcum Powder Cases: JCCP 4872 in California, involving hundreds of plaintiffs. In addition to the federal lawsuits pending against J&J and other defendants, there are also around 3,000 talcum powder cancer lawsuits pending in state courts throughout the country, and similar litigations are filed in Missouri, New Jersey, and Delaware state courts, as well as New Jersey Federal Court.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.